Seeking Alpha

GlaxoSmithKline (GSK -0.8%) says it's planning to review its European operations in response to...

GlaxoSmithKline (GSK -0.8%) says it's planning to review its European operations in response to continued pressure on drug prices in Europe and lower overall demand for vaccines. Although it's unclear on what impact the review could have on staff numbers, consensus opinion is that the move signals downsizing.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector